Skip to main content
Erschienen in: Nuclear Medicine and Molecular Imaging 4/2020

06.07.2020 | Case Report

68Ga DOTA-TOC Uptake in Non-ossifying Fibroma: a Case Report

verfasst von: Aysar Khalaf, Nader Hirmas, Farah Anwer, Akram Al-Ibraheem

Erschienen in: Nuclear Medicine and Molecular Imaging | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Non-ossifying fibroma (NOF) is a common benign bone tumor with a high probability of occurrence in children and adolescents. It is commonly seen in the metaphysis of long bones, eccentrically located, and can coexist with other malignant tumors such as neuroendocrine tumors (NET). To date, plain radiographs play a major role in the diagnosis of these benign bone tumors. Herein, we report the case of a 13-year-old male patient who was diagnosed with pulmonary NET and underwent right lung lobectomy for a hilar mass which later revealed a well-differentiated NET. The follow-up 68Ga DOTA-TOC PET/CT showed a focal somatostatin receptor expression in the left distal femur, with corresponding CT component findings of a well-defined osteolytic bone lesion located within the medial aspect of the left distal femoral metaphysis, strongly indicative of NOF. To the best of our knowledge, this is the first reported case of such an occurrence.
Literatur
1.
Zurück zum Zitat Hetts SW, Hinchey SD, Wilson R, Franc B. Case 110: nonossifying fibroma. Radiology. 2007;243:288–92.CrossRef Hetts SW, Hinchey SD, Wilson R, Franc B. Case 110: nonossifying fibroma. Radiology. 2007;243:288–92.CrossRef
2.
Zurück zum Zitat Hod N, Levi Y, Fire G, Ayash D, Somekh M, Horne T. Scintigraphic characteristics of non-ossifying fibroma in military recruits undergoing bone scintigraphy for suspected stress fractures and lower limb pains. Nucl Med Commun. 2007;28:25–33.CrossRef Hod N, Levi Y, Fire G, Ayash D, Somekh M, Horne T. Scintigraphic characteristics of non-ossifying fibroma in military recruits undergoing bone scintigraphy for suspected stress fractures and lower limb pains. Nucl Med Commun. 2007;28:25–33.CrossRef
3.
Zurück zum Zitat Goldin A, Muzykewicz DA, Dwek J, Mubarak SJ. The aetiology of the non-ossifying fibroma of the distal femur and its relationship to the surrounding soft tissues. J Child Orthop. 2017;11:373–9.CrossRef Goldin A, Muzykewicz DA, Dwek J, Mubarak SJ. The aetiology of the non-ossifying fibroma of the distal femur and its relationship to the surrounding soft tissues. J Child Orthop. 2017;11:373–9.CrossRef
4.
Zurück zum Zitat Herget GW, Mauer D, Kraus T, El Tayeh A, Uhl M, Norbert PS, et al. Non-ossifying fibroma: natural history with an emphasis on a stage-related growth, fracture risk and the need for follow up. BMC Musculoskelet Disord. 2016;17:147.CrossRef Herget GW, Mauer D, Kraus T, El Tayeh A, Uhl M, Norbert PS, et al. Non-ossifying fibroma: natural history with an emphasis on a stage-related growth, fracture risk and the need for follow up. BMC Musculoskelet Disord. 2016;17:147.CrossRef
5.
Zurück zum Zitat Hirmas N, Jadaan R, Al-Ibraheem A. Peptide receptor radionuclide therapy and the treatment of gastroentero-pancreatic neuroendocrine tumors: current findings and future perspectives. Nucl Med Mol Imaging. 2018;52:190–9.CrossRef Hirmas N, Jadaan R, Al-Ibraheem A. Peptide receptor radionuclide therapy and the treatment of gastroentero-pancreatic neuroendocrine tumors: current findings and future perspectives. Nucl Med Mol Imaging. 2018;52:190–9.CrossRef
6.
Zurück zum Zitat Prasad V, Ambrosini V, Alavi A, Fanti S, Baum RP. PET/CT in neuroendocrine tumors: evaluation of receptor status and metabolism. PET Clin. 2008:3355–79. Prasad V, Ambrosini V, Alavi A, Fanti S, Baum RP. PET/CT in neuroendocrine tumors: evaluation of receptor status and metabolism. PET Clin. 2008:3355–79.
7.
Zurück zum Zitat Rufini V, Calcagni ML, Baum RP. Imaging of neuroendocrine tumors. Semin Nucl Med. 2008;36:228–47.CrossRef Rufini V, Calcagni ML, Baum RP. Imaging of neuroendocrine tumors. Semin Nucl Med. 2008;36:228–47.CrossRef
9.
Zurück zum Zitat Błaż M, Palczewski P, Swiątkowski J, Gołębiowski M. Cortical fibrous defects and non-ossifying fibromas in children and young adults: the analysis of radiological features in 28 cases and a review of literature. Pol J Radiol. 2011;76:32–9.PubMedPubMedCentral Błaż M, Palczewski P, Swiątkowski J, Gołębiowski M. Cortical fibrous defects and non-ossifying fibromas in children and young adults: the analysis of radiological features in 28 cases and a review of literature. Pol J Radiol. 2011;76:32–9.PubMedPubMedCentral
10.
Zurück zum Zitat Jee WH, Choe BY, Kang HS, Suh KJ, Suh JS, Ryu KN, et al. Nonossifying fibroma: characteristics at MR imaging with pathologic correlation. Radiology. 1998;209:197–2.CrossRef Jee WH, Choe BY, Kang HS, Suh KJ, Suh JS, Ryu KN, et al. Nonossifying fibroma: characteristics at MR imaging with pathologic correlation. Radiology. 1998;209:197–2.CrossRef
11.
Zurück zum Zitat Stacy GS, Dixon LB. Pitfalls in MR image interpretation prompting referrals to an orthopedic oncology clinic. Radiographics. 2007;27:805–26.CrossRef Stacy GS, Dixon LB. Pitfalls in MR image interpretation prompting referrals to an orthopedic oncology clinic. Radiographics. 2007;27:805–26.CrossRef
12.
Zurück zum Zitat Al Ibraheem A, Bundschuh RA, Notni J, Buck A, Winter A, Wester HJ, et al. Focal uptake of 68Ga-DOTATOC in the pancreas: pathological or physiological correlate in patients with neuroendocrine tumors. Eur J Nucl Med Mol Imaging. 2011;38:2005–13.CrossRef Al Ibraheem A, Bundschuh RA, Notni J, Buck A, Winter A, Wester HJ, et al. Focal uptake of 68Ga-DOTATOC in the pancreas: pathological or physiological correlate in patients with neuroendocrine tumors. Eur J Nucl Med Mol Imaging. 2011;38:2005–13.CrossRef
13.
Zurück zum Zitat Hofman MS, Lau WF, Hicks RJ. Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, Normal patterns, pearls, and pitfalls in interpretation. Radiographics. 2015;35:500–16.CrossRef Hofman MS, Lau WF, Hicks RJ. Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, Normal patterns, pearls, and pitfalls in interpretation. Radiographics. 2015;35:500–16.CrossRef
14.
Zurück zum Zitat Reubi JC, Waser B, Schaer JC, Laissue AJ. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissue using receptor autoradiography with subtype selective ligands. Eur J Nucl Med. 2001;28:836–46.CrossRef Reubi JC, Waser B, Schaer JC, Laissue AJ. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissue using receptor autoradiography with subtype selective ligands. Eur J Nucl Med. 2001;28:836–46.CrossRef
15.
Zurück zum Zitat Boy C, Heusner TA, Poeppel TD, Redmann-Bischofs A, Unger N, Jentzen W, et al. Ga68 DOTATOC PET/CT and somatostatin receptor expression in normal human tissue: correlation of sst2 mRNA and SUVmax. Eur J Nucl Med Mol Imaging. 2011;38:1224–36.CrossRef Boy C, Heusner TA, Poeppel TD, Redmann-Bischofs A, Unger N, Jentzen W, et al. Ga68 DOTATOC PET/CT and somatostatin receptor expression in normal human tissue: correlation of sst2 mRNA and SUVmax. Eur J Nucl Med Mol Imaging. 2011;38:1224–36.CrossRef
Metadaten
Titel
68Ga DOTA-TOC Uptake in Non-ossifying Fibroma: a Case Report
verfasst von
Aysar Khalaf
Nader Hirmas
Farah Anwer
Akram Al-Ibraheem
Publikationsdatum
06.07.2020
Verlag
Springer Singapore
Erschienen in
Nuclear Medicine and Molecular Imaging / Ausgabe 4/2020
Print ISSN: 1869-3474
Elektronische ISSN: 1869-3482
DOI
https://doi.org/10.1007/s13139-020-00650-x

Weitere Artikel der Ausgabe 4/2020

Nuclear Medicine and Molecular Imaging 4/2020 Zur Ausgabe